Harrow HROW
NASDAQ HROW
$37.65 -0.20 (-0.53%)
As of: Sep 9, 2026 · 2:26 PM EDT

Harrow (HROW) EV to CFO (2010 - 2026)

Harrow (HROW) posted EV to CFO of 154.56 for Q2 2026, down 14.0% on a QoQ basis from 135.58 in Q1 2026, and up 88.38% year-over-year from 82.05 in Q2 2025.

Analysis

Harrow (HROW) EV to CFO (2010 - 2026) Analysis & Trends

Harrow has reported EV to CFO for 17 years, with the latest figure at 154.56 in Q2 2026.

  • On a quarterly basis, EV to CFO rose 88.38% year-over-year to 154.56 in Q2 2026; TTM through Jun 2026 was 241.16, a 8.84% decrease from a year earlier, with the FY2025 full-year figure at 39.92, up 177.23% from the prior year.
  • EV to CFO was 154.56 for Q2 2026 at Harrow, down from 135.58 in the prior quarter.
  • The five-year high for EV to CFO was 517.83 in Q3 2024, with the low at 1329.95 in Q2 2025.
  • Average EV to CFO over 5 years is 111.9, with a median of 69.33 recorded in 2023.
  • The sharpest annual moves came in 2022 and 2025: EV to CFO slumped 696.24% in 2022, then jumped 422.53% in 2025.
  • Over 5 years, EV to CFO stood at 91.36 in 2022, then jumped by 139.12% to 35.74 in 2023, then plunged by 280.61% to 64.54 in 2024, then surged by 422.53% to 208.17 in 2025, then slumped by 174.24% to 154.56 in 2026.
  • The last three EV to CFO figures came in at 154.56 (Q2 2026), 135.58 (Q1 2026), and 208.17 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.71 Bn 625.95 Bn 17.26 Bn
2 AbbVie 442.22 Bn 435.65 Bn 12.70 Bn
3 Merck 366.92 Bn 359.78 Bn 12.21 Bn
4 Novartis Ag 266.90 Bn 259.21 Bn 11.24 Bn
5 Pfizer 159.20 Bn 147.50 Bn 10.94 Bn
6 Sanofi 52.44 Bn 45.06 Bn 10.79 Bn
7 Revolution Medicines 44.11 Bn 44.11 Bn -
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn
9 United Therapeutics 21.50 Bn 18.84 Bn 683.80 Mn
10 Harrow 1.41 Bn 1.32 Bn 50.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -154.56
Mar 31, 2026 -135.58
Dec 31, 2025 208.17
Sep 30, 2025 103.07
Jun 30, 2025 -1,329.95
Mar 31, 2025 44.81
Dec 31, 2024 -64.54
Sep 30, 2024 517.83
Jun 30, 2024 -243.93
Mar 31, 2024 -84.65
Dec 31, 2023 35.74
Sep 30, 2023 -356.30
Jun 30, 2023 119.68
Mar 31, 2023 -74.11
Dec 31, 2022 -91.36
Sep 30, 2022 -676.37
Jun 30, 2022 29.85
Mar 31, 2022 137.96
Dec 31, 2021 -121.75
Sep 30, 2021 -84.95